Revenla Tablet, Film Coated
Product Images NDC 87367-166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revenla (NDC 87367-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Insignamedex Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51691df6 5457 3b1b E063 6394a90a0406

51691df6 5457 3b1b E063 6394a90a0406
Single white, film-coated oblong tablets of REVENLA 800 mg featuring the imprint 'K21' on one side against a plain gray background. The reverse side is plain with no visible markings. The image focuses on the tablet's shape and imprint details for identification.*
FDA Label Image

Dosage Forms And Strength (Sevelamer Carbonate Product Label)

Dosage Forms And Strength (Sevelamer Carbonate Product Label)
Label for Sevelamer Carbonate Tablets 800 mg, a human prescription drug by InsignaMedex LLC. The label indicates 270 tablets, Rx only, with storage instructions to protect from moisture and keep at controlled room temperature. Manufactured in China, the label includes a barcode and NDC 87367-166-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.